Brief: EPS Creative Health Technology Says Unit To Buy 95%, 51% And 51% Stake In Target Co's
20/09/2022 12:24
Sept 20 (Reuters) - EPS Creative Health Technology
3860.HK :
* UNIT TO BUY 95%, 51% AND 51% STAKE IN SHANGHAI EPS PHARMA
DEVELOPMENT, SUZHOU EPS TIGERMED PHARMA TECHNOLOGY & BEIJING
GLOBAL PHARMA RESEARCH, RESPECTIVELY
* DEAL FOR RMB2.9 MILLION
Source text for Eikon: ID:nHKS1dsyvB
Further company coverage: 3860.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EPS Creative Health Technology
See all newsBrief: EPS Creative Health Technology Expects HK$8-12 Million Increase In HY Loss After Taxation For
Brief: EPS Creative Health Technology Says Controlling Shareholder To Dispose Up To 130 Mln Shares
Brief: EPS Creative Health Technology Terminates Proposed Acquisition With No Liability
Brief: EPS Creative Health Technology To Acquire 16.23% Of China Genetic
Brief: EPS Creative Health Technology Enters MoU For 16.23% Equity Interest In China Genetic